|
End-of-day quote
Buenos Aires S.E.
02/11/2026
|
5-day change | 1st Jan Change | ||
| 136.00 ARS | -1.81% |
|
+0.37% | -43.45% |
| Market Cap | 5.79B 3.75M 3.35M 3.07M 2.8M 5.24M 355M 5.35M 36.71M 14.8M 187M 14.08M 13.78M 592M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 6.53B 4.23M 3.78M 3.47M 3.15M 5.91M 400M 6.03M 41.39M 16.68M 211M 15.87M 15.54M 668M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.81% | ||
| 1 week | +0.37% | ||
| Current month | -1.81% | ||
| 1 month | -3.20% | ||
| 3 months | -14.73% | ||
| 6 months | -17.58% | ||
| Current year | -43.45% |
| 1 week | 130 |  | 144 |
| 1 month | 130 | | 154 |
| Current year | 128.5 | | 260 |
| 1 year | 128.5 | | 357 |
| 3 years | 46 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 29/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 29/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.81% | +0.37% | -15.53% | +183.92% | 3.75M | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,257B | |
| -0.97% | +1.60% | +43.25% | +80.09% | 651B | |
| -2.05% | +0.73% | +32.47% | +101.62% | 510B | |
| -0.34% | -0.73% | +52.64% | +66.95% | 388B | |
| -0.78% | +5.51% | +72.55% | +44.25% | 366B | |
| +0.84% | +3.04% | +33.37% | +59.23% | 303B | |
| -0.07% | +8.08% | +12.08% | +34.94% | 288B | |
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | |
| -0.21% | +7.34% | +42.19% | +109.69% | 211B | |
| Average | -0.40% | +4.10% | +39.25% | +89.84% | 422.67B | |
| Weighted average by Cap. | -0.26% | +5.30% | +49.24% | +93.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.36M 4.79M 4.39M 3.99M 7.49M 507M 7.64M 52.45M 21.14M 268M 20.12M 19.69M 846M | 6.4B 4.15M 3.7M 3.4M 3.09M 5.8M 393M 5.91M 40.59M 16.36M 207M 15.57M 15.23M 655M |
| Net income | -1.42B -918K -820K -752K -684K -1.28M -86.91M -1.31M -8.98M -3.62M -45.87M -3.45M -3.37M -145M | -4.6B -2.98M -2.66M -2.44M -2.22M -4.16M -282M -4.24M -29.14M -11.75M -149M -11.18M -10.94M -470M |
| Net Debt | 863M 559K 499K 458K 417K 781K 52.93M 797K 5.47M 2.21M 27.94M 2.1M 2.05M 88.24M | 738M 478K 427K 391K 356K 668K 45.24M 681K 4.68M 1.88M 23.88M 1.79M 1.76M 75.42M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | ARS 136.00 | -1.81% | 3,263 |
| 30/10/26 | ARS 138.50 | -0.72% | 10,354 |
| 29/10/26 | ARS 139.50 | +2.57% | 1,200 |
| 28/10/26 | ARS 136.00 | -0.37% | 10,969 |
| 27/10/26 | ARS 136.50 | +0.74% | 17,143 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
